• ForeQube: Top Pharma Companies by Global Revenue 2024-2025

    ForeQube presents the latest analysis on the top pharma companies by global revenue in 2024 and 2025. As the pharmaceutical industry continues to evolve, 2024 proved to be a defining year for innovation, drug development, and corporate growth. The year saw major pharmaceutical giants not only maintaining their stronghold on the market but also making…

    Read More

  • Case Scenario: Enhancing Clinical Trial Success Through Data Insights

    Case Scenario: Enhancing Clinical Trial Success Through Data Insights

    Client: A pharmaceutical company developing therapies for oncology.Challenge: Recruitment delays and lack of clarity on competitive research activities.Goal: Streamline recruitment, reduce trial timelines, and identify whitespaces for future pipeline expansion. ForeQube’s Solution: Utilizing the Clinical Trial Dashboard ForeQube provided insights into ongoing and upcoming oncology trials globally.The client identified regions with higher patient density for…

    Read More

  • The Role of Data-Driven Insights in Shaping the Future of Healthcare and Lifesciences

    The Role of Data-Driven Insights in Shaping the Future of Healthcare and Lifesciences

    Introduction The healthcare and lifesciences industries are experiencing a seismic shift, driven by advancements in data analytics, market research, and predictive forecasting. Organizations now have access to vast amounts of data—from patient records and clinical trials to market trends and sales analytics—that can revolutionize decision-making. At ForeQube, we specialize in transforming complex data into actionable…

    Read More

  • FMCG Growth Hits a Speed Bump: Can Data-Driven Insights Accelerate the Comeback?

    FMCG Growth Hits a Speed Bump: Can Data-Driven Insights Accelerate the Comeback?

    The Indian Fast-Moving Consumer Goods (FMCG) sector has long been a cornerstone of economic growth, fueled by both urban and rural consumption. However, recent data paints a challenging picture: growth has slowed to just 4% in the last two quarters, reflecting softer demand across key segments. What’s causing this slowdown, and more importantly, how can…

    Read More